- Home
- VALN
VALN
Valneva SE
as 11-15-2024 4:00pm EST
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates the majority of its revenue from product sales.
| Founded: | 2012 | Country: | France |
| Employees: | N/A | City: | N/A |
| Market Cap: | 488.9M | IPO Year: | 2021 |
| Target Price: | $18.50 | AVG Volume (30 days): | 22.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.06 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.60 - $12.85 | Next Earning Date: | 11-07-2024 |
| Revenue: | $176,817,979 | Revenue Growth: | -28.98% |
| Revenue Growth (this year): | 24.3% | Revenue Growth (next year): | 16.05% |
Latest Valneva SE News
VALN Breaking Stock News: Dive into VALN Ticker-Specific Updates for Smart Investing
The Wall Street Journal
2 days ago
European Vaccine Makers Under Pressure After Trump Picks RFK Jr to Lead Health Department
GlobeNewswire
4 days ago
Valneva and LimmaTech Announce First Vaccination in Phase 2b Human Challenge Study of Tetravalent Shigella Vaccine Candidate S4V2
GlobeNewswire
6 days ago
Valneva to Present and Hold Investor Meetings at Upcoming U.S. and European Healthcare Conferences
GuruFocus.com
9 days ago
Valneva SE (INRLF) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and Improved ...
GlobeNewswire
11 days ago
Valneva Reports Nine-Month 2024 Financial Results and Provides Corporate Updates
GuruFocus.com
11 days ago
Valneva SE (VALN) Q3 2024 Earnings Report Preview: What to Look For
GlobeNewswire
11 days ago
VALNEVA - Declaration of shares and voting rights: October 31, 2024
Simply Wall St.
23 days ago
High Growth Tech Stocks in France to Watch October 2024
Compare VALN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VALN Valneva SE - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.